Publications en collaboration avec des chercheurs de Hospital Universitario Doctor Peset (40)

2011

  1. Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyperprolactinemia

    Fertility and Sterility, Vol. 95, Núm. 3

2010

  1. Twins born after transplantation of ovarian cortical tissue and oocyte vitrification

    Fertility and Sterility, Vol. 93, Núm. 1, pp. 268.e11-268.e13

2008

  1. Clinical factors affecting endometrial receptiveness in oocyte donation cycles

    Fertility and Sterility, Vol. 89, Núm. 3, pp. 491-501

  2. Endometrial receptivity and implantation are not affected by the presence of uterine intramural leiomyomas: A clinical and functional genomics analysis

    Journal of Clinical Endocrinology and Metabolism, Vol. 93, Núm. 9, pp. 3490-3498

  3. Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome

    Human Reproduction Update, Vol. 14, Núm. 4, pp. 321-333

2007

  1. Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction

    Journal of Clinical Endocrinology and Metabolism, Vol. 92, Núm. 8, pp. 2931-2937

  2. Fresh human orthotopic ovarian cortex transplantation: Long-term results

    Human Reproduction, Vol. 22, Núm. 3, pp. 786-791

  3. Serum interleukin-6 levels are elevated in women with minimal-mild endometriosis

    Human Reproduction, Vol. 22, Núm. 3, pp. 836-842

2006

  1. Effect of sperm glutathione peroxidases 1 and 4 on embryo asymmetry and blastocyst quality in oocyte donation cycles

    Fertility and Sterility, Vol. 86, Núm. 5, pp. 1376-1385

  2. Heteroparental blastocyst production from microsurgically corrected tripronucleated human embryos

    Fertility and Sterility, Vol. 86, Núm. 6, pp. 1601-1607

  3. Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model

    Endocrinology, Vol. 147, Núm. 11, pp. 5400-5411

2005

  1. Age and uterine receptiveness: Predicting the outcome of oocyte donation cycles

    Journal of Clinical Endocrinology and Metabolism, Vol. 90, Núm. 7, pp. 4399-4404

  2. El banco de semen en una clínica de reproducción humana: Métodos, organización e indicaciones

    Jornal Brasileiro de Reproducao Assistida

  3. Especies reactivas del oxígeno: Papel en fertilidad masculina y en ciclos de congelación-descongelación de espermatozoides

    Jornal Brasileiro de Reproducao Assistida

  4. Semen characteristics in human immunodeficiency virus (HIV)- and hepatitis C (HCV)-seropositive males: Predictors of the success of viral removal after sperm washing

    Human Reproduction, Vol. 20, Núm. 4, pp. 1028-1034

  5. Serum luteinizing hormone in patients undergoing ovarian stimulation with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone and its relationship with cycle outcome

    Fertility and Sterility, Vol. 84, Núm. 5, pp. 1529-1532

2004

  1. Administration of low-dose LH induces ovulation and prevents vascular hyperpermeability and vascular endothelial growth factor expression in superovulated rats

    Reproduction, Vol. 127, Núm. 4, pp. 483-489

  2. Comparison of two different starting multiple dose gonadotropin-releasing hormone antagonist protocols in a selected group of in vitro fertilization-embryo transfer patients

    Fertility and Sterility, Vol. 81, Núm. 3, pp. 562-566

  3. Concentration of glutathione and expression of glutathione peroxidases 1 and 4 in fresh sperm provide a forecast of the outcome of cryopreservation of human spermatozoa

    Journal of Andrology, Vol. 25, Núm. 5, pp. 773-780

  4. El diagnóstico genético preimplantacional y sus nuevas indicaciones en reproducción asistida

    Clinica e Investigacion en Ginecologia y Obstetricia, Vol. 31, Núm. 9, pp. 314-322